8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-18-013796
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a8kvibativacquisitionannou.htm…